Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 3 1Phase 1 1

Status

Terminated 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Glioblastoma 28Lung Neoplasms 13Gliosarcoma 13Carcinoma, Non-Small-Cell Lung 13Rectal Neoplasms 12Brain Neoplasms 11Squamous Cell Carcinoma of Head and Neck 10Sarcoma 9Prostatic Neoplasms 9Breast Neoplasms 9Astrocytoma 9Uterine Cervical Neoplasms 8Melanoma 8Glioma 8Esophageal Neoplasms 8Pancreatic Neoplasms 7Head and Neck Neoplasms 7Neoplasm Metastasis 5Lymphoma, Follicular 5Oropharyngeal Neoplasms 4Lymphoma, Mantle-Cell 4Leukemia, Lymphocytic, Chronic, B-Cell 4Carcinoma, Squamous Cell 4Stomach Neoplasms 3Ovarian Neoplasms 3Multiple Myeloma 3Mouth Neoplasms 3Lymphoma, Large B-Cell, Diffuse 3Lymphoma, B-Cell, Marginal Zone 3Lymphoma, B-Cell 3

Interventions

Radiotherapy 3Paclitaxel 3Taxes 2Etoposide 2Erlotinib Hydrochloride 2Docetaxel 2Cisplatin 2Carboplatin 2Bevacizumab 2vandetanib 1sargramostim 1romidepsin 1motesanib diphosphate 1advexin 1Vinorelbine 1Topotecan 1Soybean Proteins 1Radiotherapy, Conformal 1Radiation 1Pemetrexed 1Gemcitabine 1Gefitinib 1Doxorubicin 1Diathermy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Adenocarcinoma, Bronchiolo-Alveolar × Radiation × Clear all
NCT00042835 2013-02-01

Erlotinib and Radiation Therapy Plus Combination Chemotherapy in Treating Patients With Inoperable Stage III Non-Small Cell Lung Cancer

National Cancer Institute (NCI)

Phase 1 Terminated
48 enrolled
Thoracic

Adenocarcinoma of Lung, Adenocarcinoma, Bronchiolo-Alveolar, Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡